<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20231027059868N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-11-18</date_registration>
      <primary_sponsor>Khyber Medical University</primary_sponsor>
      <public_title>THE EFFECTS OF FUNCTIONAL RELEASE AND POSITIONAL RELEASE TECHNIQUES ON UPPER TRAPEZIUS MYALGIA AND CERVICAL RANGE OF MOTION; “A DOUBLE BLINDED RANDOMIZED CONTROLLED TRIAL”.</public_title>
      <acronym></acronym>
      <scientific_title>THE EFFECTS OF FUNCTIONAL RELEASE AND POSITIONAL RELEASE TECHNIQUES ON UPPER TRAPEZIUS MYALGIA AND CERVICAL RANGE OF MOTION; “A DOUBLE BLINDED RANDOMIZED CONTROLLED TRIAL”.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-10-31</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/73462</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Participants’ recruitment for the study were be done through non-probability convenience sampling and then randomly assigned to either group A or group B through sealed envelope, Blinding description: the subjects will be divided into two groups, thirty subjects in each group will be recruited from 
NWGH’s Musculoskeletal Physiotherapy OPD. Informed consent will be taken from every 
single subject in their language best understood by them. The participants will not be inform about their group assignments prior to randomization. A consent form will be obtained once the patients fulfill the inclusion criteria. All of the participants required to choose one of the 60 papers from an envelope 
following the first evaluation round. Thirty papers had TG1 printing, and the remaining had
TG2 printing. The papers in the envelope all will be mixed up. Each participant's choice of 
paper led to their appropriate grouping, which was TG1 for the FRT group and TG2 for the 
PRT. The volunteers selected also unaware of their group's features, and both groups will be 
assessed by an experienced physiotherapist colleague, who is also unaware about participate 
allocation in groups. Every participant received a total of three sessions per day for one week.</study_design>
      <phase>0 (exploratory trials)</phase>
      <hc_freetext>..</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Functional release technique. Intervention 2: Intervention group: 2 positional release technique.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
THE EFFECTS OF FUNCTIONAL RELEASE AND POSITIONAL RELEASE TECHNIQUES ON UPPER TRAPEZIUS MYALGIA AND CERVICAL RANGE OF MOTION; “A DOUBLE BLINDED RANDOMIZED CONTROLLED TRIAL”

When:
data will be available for researchers, scholars and students

To whom:
data will bee available for master students and registered participants with IRCT.

Conditions:
data will bee available for master students and registered participants with IRCT.

Where to obtain:
data will be obtained by emailing the principle author .(ayeshameedpt@gmail.com)

How to obtain:
the researcher who required data mail the concern author..(ayeshameedpt@gmail.com)

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Ayesha</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>F1 Phase-6 Rd, Phase 5 Hayatabad, Peshawar, Khyber Pakhtunkhwa 25100</address>
        <city>Peshawar</city>
        <country1>Pakistan</country1>
        <zip>25000</zip>
        <telephone>+92 91 5862514</telephone>
        <email>ayeshameedpt@gmail.com</email>
        <affiliation>Khyber Medical University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Ayesha</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>F1 Phase-6 Rd, Phase 5 Hayatabad, Peshawar, Khyber Pakhtunkhwa 25100</address>
        <city>Peshawar</city>
        <country1>Pakistan</country1>
        <zip>25000</zip>
        <telephone>+92 91 5862514</telephone>
        <email>ayeshameedpt@gmail.com</email>
        <affiliation>Khyber Medical University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age 18 to 45 years with Upper Trapezius myalgia..
Males/females
Pain intensity of 4 to 7 on NPRS will be included in the study.
Pain for more than one week.</inclusion_criteria>
      <agemin>14 years</agemin>
      <agemax>45 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>A patient will be excluded if suffering from, acute facet joint locking, and pregnancy
Patient with cervical radiculopathy, ligamentous instability, and recent TOS (Through special tests).
Diagnosed cases of Fibro-myalgia syndrome, fractures, and recent injuries to the shoulder or cervical spine, neck, vascular disorder, scapula or any surgical procedures.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M79.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Myalgia</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>N/A</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Functional release technique</i_keyword>
      <i_keyword>Intervention group: 2 positional release technique</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>To decrease pain. Timepoint: 1, 3,  7 day after intervention. Method of measurement: Numerical pain rating scale ,and goniometer for Range of motion.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Khyber Medical University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-06-20</approval_date>
        <contact_name>KHYBER MEDICAL UNIVERSITY ETHICS BOARD.</contact_name>
        <contact_address>F1 Phase-6 Rd, Phase 5 Hayatabad, Peshawar, Khyber Pakhtunkhwa 25100 PESHAWAR KHYBER PAKHTUNKHWA, PAKISTAN Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
